Erweiterte Suche
Wertpapiere
Name | Mnemo | Börse | Durchschn. Volumen | Kurs | Typ | |
---|---|---|---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | Japan Exchange +8 Andere | 3 469 807 | 4.192 JPY | Aktie | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | Deutsche Boerse AG | 340 | 24,88 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | London S.E. | 0 | 37,59 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | Börse Stuttgart | - | 24,35 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | BOERSE MUENCHEN | 112 | 24,77 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | OTC Markets | 2 037 | 26,86 USD | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Wiener Boerse | - | 24,82 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | Fukuoka Stock Exchange | 0 | 4.080 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 853849 | Sapporo S.E. | 0 | 4.300 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAKP34 | Sao Paulo | 413 | 69,86 BRL | Aktie | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | Nyse +5 Andere | 1 258 872 | 13,36 USD | Aktie | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | Mexican S.E. | 4 851 | 240,5 MXN | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | Deutsche Boerse AG | - | 12,1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | Börse Stuttgart | - | 12,1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | BOERSE MUENCHEN | - | 12,3 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A1CWZF | London S.E. | 843 | 13,07 USD | ||
TAKEDA IP HOLDINGS CO.,LTD. | 899140 | Japan Exchange | 8 160 | 852 JPY | Aktie | |
TAKEDA MACHINERY CO., LTD. | 565261 | Japan Exchange | 7 113 | 3.340 JPY | Aktie | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A2RUPU | Deutsche Boerse AG | - | 95,93 % | Anleihe | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A28ZJH | BOERSE MUENCHEN | - | 91,72 % | Anleihe | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A28ZJK | BOERSE MUENCHEN | - | 83,96 % | Anleihe | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A28ZJJ | BOERSE MUENCHEN | - | 88,2 % | Anleihe | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | A2RUPU | BOERSE MUENCHEN | - | 96,18 % | Anleihe |
Unternehmen (6)
Takeda Pharmaceutical Company Limited ist auf die Entwicklung, Herstellung und Vermarktung von pharmazeutischen Produkten insbesondere für Stoffwechsel- und Herz-Kreislauf-Erkrankungen, Krebserkrankungen und Störungen des zentralen Nervensystems spezialis ...
Takeda iP Holdings Co Ltd, ehemals Takeda Printing Co Ltd, ist hauptsächlich im Druckgeschäft tätig. Das Unternehmen ist in zwei Geschäftsbereichen tätig. Das Segment Druck hat zwei Geschäftsbereiche. Das Druckgeschäft befasst sich mit der Planung und Pro ...
Affymax, Inc. ist ein biopharmazeutisches Unternehmen. Das Produkt OMONTYS (Peginesatid) des Unternehmens ist für die Behandlung von Anämie aufgrund chronischer Nierenerkrankungen bei erwachsenen Dialysepatienten bestimmt. OMONTYS ist ein synthetisches, p ...
TAKEDA MACHINERY CO., LTD. ist ein Unternehmen mit Sitz in Japan, das sich hauptsächlich mit der Herstellung und dem Verkauf von Maschinen zur Bearbeitung von Formstahl und Kreissägemaschinen für die Bearbeitung von Stahlrahmen, Stahlmaterialien, Blechen ...
Ligand Pharmaceuticals Incorporated ist ein biopharmazeutisches Unternehmen, das den wissenschaftlichen Fortschritt durch die Unterstützung der klinischen Entwicklung von Medikamenten fördert. Das Unternehmen tut dies durch die Bereitstellung von Finanzmi ...
DRI Healthcare Trust ist ein in Kanada ansässiges Unternehmen, das sich mit der Bereitstellung von Finanzmitteln zur Förderung von Innovationen in der Biowissenschaftsbranche beschäftigt. Das Unternehmen ist in der Monetarisierung von pharmazeutischen Liz ...
Insiders
Norimasa Takeda ist Chief Accounting Officer & Corporate Controller bei Takeda Pharmaceutical Co., Ltd.
Derzeit ist Norimasa Kitazawa President & Representative Director bei Pigeon Corp.
Gegenwärtig bekleidet Norimasa Sato die Position des Chief Financial Officer & Senior Managing Director bei Welcia Holdings Co., Ltd. und des Wirtschaftsprüfers von Welcia Kaigo Service Co., Ltd. Herr Sato ist außerdem Mitglied des Vorstands von Welcia Yakkyoku Co., Ltd. In seiner früheren Karriere hatte er die Position des Corporate Auditors bei Ouen Kazoku Co., Ltd. inne.
Derzeit hat Kazunori Takeda die Position des Executive Vice President & President-Commerce bei Rakuten, Inc. inne. Herr Takeda ist außerdem Mitglied des Vorstands von Gurunavi, Inc., Rakuten General Insurance Co., Ltd., Fusion Communications Corp. und Rakuten Vissel Kobe, Inc. Er erhielt einen MBA von der Harvard Business School.
Kazuhiko Takeda ist Mitglied des Vorstands von Sony (China) Co., Ltd. und Executive Officer bei Sony Corp.
Derzeit bekleidet Chikashi Takeda die Position des Chief Financial Officer bei Olympus Corp. In der Vergangenheit hatte er die Position des Senior Executive Officer & Head-Finance bei Astellas Pharma, Inc. inne.
Norimasa Wada formerly worked at WADAKOHSAN CORP., as Chairman from 2008 to 2022.
Mr. Wada received his graduate degree in 1962 from Faculty of Law, Keio University and undergraduate degree in 1957 from Hyogo Technical High School.
Norimasa Maida formerly worked at Toyo Seikan Group Holdings Ltd., as Director & Managing Executive Officer from 2015 to 2016 and Toyo Kohan Co., Ltd., as Executive Officer & GM-Chemical Products Planning from 2011 to 2016.
Norimasa Shinya is currently working as a Senior Analyst at Mizuho Securities Co., Ltd.
(Broker).
Norimasa Matsuoka formerly worked at TTCL Public Co. Ltd., as Director and Chiyoda Corp., as Manager-Petroleum & Petrochemicals Group from 2000 to 2015.
Mr. Matsuoka received his graduate degree from Keio University.
Norimasa Kunimoto currently works at Terumo Europe NV (Belgium), as Chief Executive Officer from 2018, Terumo France SAS, as Chairman, Terumo (Deutschland) GmbH, as Co-Managing Director, and Terumo UK Ltd., as Director.
Norimasa Yamamizu is currently working as the Director, Executive Officer & GM-Foodstuffs at Shinyei Kaisha.
Norimasa Tanabe is currently a Partner at Ant Capital Partners Co., Ltd.
since 2009.
He previously worked as a Director at Kagayaku Cosmetics, Inc.
Norimasa Iida currently works at ONO SOKKI Co., Ltd., as Independent Outside Director from 2019.
Mr. Norimasa Ogawa is a Research Analyst at Daiwa Securities Capital Markets Co. Ltd.
Norimasa Komatsu is currently the President & Representative Director at Genesis Technology, Inc. since 1997.
Prior to this, he worked at Kobe Steel, Ltd.
as a Principal from 1974 to 1998.
Norimasa Kuroda is currently the Chairman of Shouohkai Foundation and a Non-Executive Director at JTB Corp.
He previously held positions as Chairman at Mizuho Trust & Banking Co., Ltd., Independent Outside Director at Tokyo Tatemono Co., Ltd., Outside Director at Sompo Japan Insurance, Inc., and Deputy President at Mizuho Bank Ltd.
Norimasa Takeshima held the position of President & Representative Director at Daido Sittipol Co. Ltd.
and Executive Officer at Daido Kogyo Co., Ltd.
Norimasa Kamura worked as a Manager of Personnel & General Affairs at Daiichi Sankyo Co., Ltd.
Norimasa Okubo currently works as an Executive Officer at Kokubu Group Corp.
Norimasa Yoshida is an Independent Outside Director at Benefit Japan Co., Ltd.
since 2016.
He previously held positions as Chairman at Senshu Ikeda Holdings, Inc. and The Senshu Ikeda Bank Ltd., and as President at Senshu Bank Ltd.
Norimasa Sato currently works at Takamisawa Co., Ltd., as Senior Managing Director.
Norimasa Somiya held positions as a Director at Osaka Steel Co., Ltd., an Independent Director at Chubu Steel Plate Co., Ltd., and a Manager at Nagoya Steel Plant for Nippon Steel Corp.
Norimasa Nosaka has a current job as Co-Managing Director at BBS Motorsport GmbH.
Norimasa Sakata has worked as an Auditor at Mitani Sangyo Co., Ltd.
since 2016.
Norimasa Tsunemi has a current job as the Director, Head-Accounting & Finance at Ensuiko Sugar Refining Co., Ltd.
Norimasa Kurata currently works at Union Tool Co., as Executive Officer & General Manager-Administration.
Mitsuhiro Takeda worked as the General Manager of Import Products Department at Kanematsu Corp from 1986 to 2005.
He was the Chairman of coen Co., Ltd.
and the President & Representative Director of UNITED ARROWS LTD.
from 2012 to 2021.
Shigeru Takeda worked as an Executive Officer & Deputy GM-Construction at Asanuma Corp.
Hiroyasu Takeda is currently a Senior Managing Director at Fujitsu Client Computing Ltd.
Prior to this, he worked at Fujitsu Ltd.
from 2010 to 2016, where he held the position of Executive VP & Head-Personal Systems Business Unit from 2014 to 2016.
Munetaka Takeda worked as a Representative Director, VP& Head-Compliance at Japan Tobacco, Inc. in 2012.
Tetsuo Takeda is the founder of Takeda Management Systems Co., Ltd.
which was founded in 1978.
He held the title of Representative Director.
Mr. Takeda also held former positions as an Outside Director at Daito Trust Construction Co. Ltd.
from 2010 to 2011 and as a Director at Studio F Co., Ltd.
Katsuaki Takeda worked at Japan Aviation Electronics Industry Ltd.
from 1971 to 2010, where he held the position of Director & Senior Vice President.
Masahito Takeda worked as a Senior Executive Officer at Pacific Metals Co., Ltd.
Eiichi Takeda worked as a Director & General Manager-Global Sales at Advanex Inc. from 2015 to 2017.
Zengo Takeda worked at Tobu Railway Co., Ltd.
as a Senior Managing Representative Director from 2010 to 2014.
Yoshiaki Takeda worked at Oji Holdings Corp.
from 1977 to 2020, where he held the position of Director & Senior Managing Executive Officer from 2018 to 2020.
He also worked as President at Oji Management Office, Inc.
Kazushige Takeda has a current job as the Director & Head-Sales at ktk, Inc.
Nobuo Takeda is currently a Director at Nissho Inter Life Co., Ltd.
He was previously a Director at NIL Telecom KK and a Director at InterLife Holdings Co., Ltd.
from 2007 to 2011.
Satoshi Takeda worked as a Vice President at AMB Property Corp.
Nobuo Takeda is currently a Director at Ball Wave Inc. and was previously the Chief Technical Officer & Senior Vice President at BALL Semiconductor, Inc. He has also worked as a Researcher at JST Co., Ltd., a Manager of Communications Design at System Research Co., Ltd., and a Researcher at Semiconductor Research Corp.
Takeda received his doctorate degree from Tohoku University in 1985.
Dr. Kenji Takeda, MD, is on the Board of Directors at Soliton Systems KK.
Dr. Takeda was previously employed as Senior Vice President by Hitachi Corporate Ventures Catalyst Fund.
Keine Ergebnisse zu dieser Suche
- Börse
- Erweiterte Suche
- Norimasa Takeda